Los Angeles, CA, United States of America

Daniel Broek

USPTO Granted Patents = 5 


Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 2008-2010

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Daniel Broek

Introduction

Daniel Broek is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of biotechnology, particularly in the development of humanized collagen antibodies. With a total of 5 patents to his name, Broek's work has the potential to impact various medical applications.

Latest Patents

One of Broek's latest patents focuses on humanized collagen antibodies and related methods. This invention provides a grafted antibody, or functional fragment thereof, comprising one or more complementarity determining regions (CDRs) with at least one amino acid substitution in one or more CDRs of a heavy chain CDR. The grafted antibody or functional fragment exhibits specific binding activity for a cryptic collagen epitope. Additionally, the invention outlines methods for using this antibody to inhibit angiogenesis, tumor growth, and metastasis.

Career Highlights

Daniel Broek has established himself as a key figure in his field through his innovative research and development efforts. His work at Cell Matrix, Inc. has allowed him to explore new frontiers in antibody technology. His contributions are recognized for their potential to advance therapeutic strategies in oncology and regenerative medicine.

Collaborations

Broek has collaborated with notable colleagues, including Jeffry Dean Watkins and William D Huse. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Daniel Broek's innovative work in the field of biotechnology, particularly with humanized collagen antibodies, showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic approaches that could significantly benefit patients in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…